Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice

Keizo Sato, Moritaka Suga, Takaaki Akaike, Shigemoto Fujii, Hiroyuki Muranaka, Toshinori Doi, Hiroshi Maeda, Masayuki Ando

Research output: Contribution to journalArticlepeer-review

92 Citations (Scopus)

Abstract

Erythromycin (EM) is an antibiotic with potent antiinflammatory effects that is used for treating chronic lower respiratory tract infections. It has been shown that free radicals, such as the Superoxide anion and nitric oxide (NO), are pathogenic molecules in viral disease. Much attention has been given to a critical role of NO in the pathologic events of various inflammatory diseases. In the present study, we evaluated the effects of EM on influenza-virus-induced pneumonia in mice infected with a lethal dose of influenza virus A/Kumamoto/Y5/67 (H2N2). The administration of EM at a dose of 3.3 mg/kg/d (intraperitoneally, from Days 1 to 6 after infection), significantly improved the survival rate of mice infected with influenza virus, and the survival rate of the virus-infected mice at Day 20 after infection increased in a dose-dependent fashion with EM administered to the animals, from 14% among controls to 42% among animals given EM at 1.0 mg/kg/d and 57% among those given EM at 3.3 mg/kg/d. The induction of interferon-γ (IFN-γ) in the mouse lung was inhibited by EM treatment on Day 6 after infection. Simultaneously, the number of inflammatory cells recovered in lung lavage fluid 6 d after virus infection was significantly reduced by the treatment with EM. The EM treatment resulted in a dose-dependent decrease in the level of nitrite/nitrate (metabolites of NO) in the serum and the NO synthase (NOS)-inducting potential in the lungs of the virus-infected mice. These results indicate that EM may have substantial therapeutic value for various acute inflammatory disorders such as influenza-virus-induced pneumonia, by inhibiting inflammatory-cell responses and suppress-ing NO overproduction in the lung.

Original languageEnglish
Pages (from-to)853-857
Number of pages5
JournalAmerican journal of respiratory and critical care medicine
Volume157
Issue number3 PART I
DOIs
Publication statusPublished - 1998

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice'. Together they form a unique fingerprint.

Cite this